Navigation Links
Genome of marine organism reveals hidden secrets
Date:5/9/2011

An international team of researchers led by scientists at Scripps Institution of Oceanography at UC San Diego has deciphered the genome of a tropical marine organism known to produce substances potentially useful against human diseases.

Tiny photosynthetic microorganisms called cyanobacteria are some of the oldest forms of life on the planet. At times their emergence as toxic blooms causes a threat to humans and animals. But despite the recognized capability of marine strains of the cyanobacterial genus Lyngbya, and specifically the species L. majuscula, to create hundreds of natural products with biomedical promise, surprisingly little is known about the genetics underlying their production.

In this week's online early edition of the Proceedings of the National Academy of Sciences, a research team led by Scripps graduate student Adam Jones and postdoctoral fellow Emily Monroe, both in the Gerwick laboratory at Scripps Institution of Oceanography's Center for Marine Biotechnology and Biomedicine (CMBB), provide the first insights of the genome of Lyngbya majuscula 3L, a Caribbean organism that generates compounds that are being developed for potential treatment against cancer and neurodegenerative diseases.

"These compounds have gained considerable attention due to their pharmaceutical and biotechnology potential, but they are also notorious for their environmental toxicity and threats to humans, wildlife and livestock," the authors note in their paper.

In the marine environment the wiry, or "filamentous," cyanobacteria play a vital role in the global carbon cycle. Lyngbya strains are known to disrupt the healthy growth of coral reefs and are behind the agents responsible for a skin rash known as "swimmer's itch."

Achieving the first genomic sequencing of its kind for the filamentous Lyngbya majuscula 3L, the research team overcame several obstacles due to the organism's complex, intermeshed growth in the wild with a range of other bacteria, muddying a clear picture of the genome. The team undertook several different research tactics and experiments, including single cell genome amplification, protein and metabolite profiling.

The results revealed a complex gene network suggesting an enhanced ability of the organism to adapt to shifting conditions in the marine environment.

Sequencing was done at the Max Planck Institute in Berlin, Germany and at the J.Craig Venter Institute in Rockville, Maryland. Much of the assembly was conducted by Sheila Podell, a project scientist in the Eric Allen laboratory at Scripps. Jones and Monroe traced the genomic pathways and performed tests to understand which genes encoded the production of different natural products.

Yet as much as the genome revealed about Lyngbya majuscula 3L, the researchers also uncovered key information about its limitations and shortcomings. For example, it's been assumed that Lyngbya majuscula 3L and its cousins in the Lyngbya genus convert, or "fix," nitrogen from the atmosphere into organic molecules, a fundamental natural process in the global environment. To their surprise, Lyngbya majuscula 3L lacks the genes necessary for nitrogen fixation, even though reports exist that this species fixes nitrogen.

"It's possible that strains of L. majuscula reported to fix nitrogen may have been misidentified because it is visually very similar to other filamentous cyanobacteria species and we found that this marine strain doesn't seem capable of fixing nitrogen on its own," said Monroe. "This feature could be a distinction between the freshwater and the marine strains of what is currently characterized as Lyngbya."'

And while marine Lyngbya strains are proven prolific generators of natural products with biomedical and pharmaceutical potential, the new study shows that more work is needed to pinpoint which species generates which natural products. Jones says that more than 250 compounds are attributed to marine Lyngbya strains. Of those, nearly three-quarters are linked to Lyngbya majuscula. However, the Lyngbya majuscula 3L strain was found to only produce a small number of natural products.

"This particular strain doesn't produce nearly as many (natural products) as we thought it might, which shows that many of the interesting molecules discovered to date are probably scattered among multiple organisms," said Jones. "The lesson learned is that not all marine Lyngbya strains are created equal."

"This may change the way we start looking at things in the field and give us new ways to identify organisms," said Lena Gerwick, the faculty member who organized this genomic project from the beginning. "We might be able to turn things around and use the compounds they make as a new way of determining what kinds of species they are."


'/>"/>

Contact: Mario Aguilera or Robert Monroe
scrippsnews@ucsd.edu
858-534-3624
University of California - San Diego
Source:Eurekalert  

Related medicine news :

1. Genome Scans May Reveal Life-Saving Alternatives for Cancer Patients
2. Mouse cancer genome unveils genetic errors in human cancers
3. Genome sequencing used to assess a novel form of Clostridium botulinum
4. WSU study may lead to greater understanding of human genome regulation
5. IDIBELL researchers discover a substance against the dark genome of cancer
6. Whole genome sequencing used to help inform cancer therapy
7. First Look at Prostate Cancer Genome Yields Insights
8. Orangutan Genomes Reveal Some Surprises
9. Punctuated evolution in cancer genomes
10. Genome code cracked for most common form of pediatric brain cancer
11. Targeted therapy reactivates guardian of the genome in resistant cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genome of marine organism reveals hidden secrets
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
Breaking Medicine Technology: